Live prices from 22 SA suppliers, from R279.00, compared side by side so you never overpay.
Copy the code — you'll paste it at checkout.
with our exclusive code
You're about to visit an external supplier
with our exclusive code
By clicking "Continue", you acknowledge that you understand and accept the above. Read our full disclosure.
Try removing a filter or two to widen the search.
Try removing a filter or two to widen the search.
More ways to compare KPV
Different views of the same live SA pricing, tuned for how you like to shop.
Compare another peptide
All purchases are made directly from third-party suppliers; your relationship is solely with them. We accept no liability for the quality, purity, or legality of any products listed.
We may earn a commission when you click through to a supplier and make a purchase. This does not affect pricing information displayed.
By using this site you accept responsibility for ensuring purchases comply with applicable laws in your jurisdiction. Read our full disclosure.
Anti-Inflammatory Tripeptide | Alpha-MSH Fragment
KPV is a potent anti-inflammatory tripeptide derived from the C-terminal of alpha-MSH. It exhibits remarkable anti-inflammatory and antimicrobial properties without the pigmentation effects of full α-MSH, making it ideal for inflammation management.
Enters cells and inhibits inflammatory pathways at the nuclear level, particularly NF-κB signaling. Reduces pro-inflammatory cytokines (TNF-α, IL-6) without causing immunosuppression like steroids.
Reduces TNF-α and IL-6 through NF-κB pathway inhibition.
May help balance overactive immune responses in autoimmune conditions.
Potential benefits for inflammatory arthritis through cytokine reduction.
Demonstrated benefit in Crohn's disease and ulcerative colitis models.
Helps restore intestinal barrier function.
Selective antimicrobial activity preserves beneficial gut bacteria.
Topical KPV reduced psoriatic markers by 60% and improved skin barrier function.
Reduces inflammatory skin conditions without systemic effects.
Subcutaneous injection provides systemic anti-inflammatory effects. Abdomen is preferred for gut-related issues.
| Goal | Dose | Frequency | Route |
|---|---|---|---|
| General anti-inflammatory | 200-300mcg | Once daily | SubQ |
| Active inflammation | 250mcg | Twice daily | SubQ |
| Autoimmune support | 500mcg | Once daily | SubQ |
| Acute flare-ups | 500mcg | 2x daily for 1 week, then reduce | SubQ |
Oral administration provides direct gut exposure for intestinal conditions.
| Goal | Dose | Frequency | Route |
|---|---|---|---|
| Gut health support | 200-500mcg | 2-3x daily | Mix in water/juice or enteric capsules |
Topical cream/gel for localized skin inflammation without systemic absorption.
| Goal | Dose | Frequency | Route |
|---|---|---|---|
| Skin inflammation | 0.1-0.5% cream/gel | 2-3x daily | Affected skin areas |
Nasal spray with limited data. May provide systemic effects through nasal absorption.
| Goal | Dose | Frequency | Route |
|---|---|---|---|
| Systemic anti-inflammatory | 100-300mcg | 2-3x daily (1-2 sprays per nostril) | Nasal spray |
Enhanced gut healing and anti-inflammatory effects through complementary mechanisms.
Different mechanisms; can be combined safely.
Complementary antimicrobial and healing effects.
Both support immune function through different pathways.
Synergistic for skin health and regeneration.
Both are α-MSH related; KPV lacks pigmentation effects but monitor for cumulative effects.
Subtle reduction in inflammation, improved energy
Noticeable decrease in inflammatory symptoms
Improved gut function (if applicable), reduced pain/swelling
Significant improvement in inflammatory markers
Sustained benefits, improved quality of life
Drug Delivery Research
Enhanced delivery methods using nanoparticle technology.
Gut Health Journal
KPV combined with probiotics for enhanced IBS treatment.
Inflammation Research
Potential application in post-COVID inflammatory conditions.
Demonstrated significant reduction in inflammatory markers and improved intestinal barrier function in IBD models.
KPV enters cells and directly inhibits NF-κB pathway, reducing TNF-α, IL-6, and other inflammatory cytokines.
Topical KPV reduced psoriatic markers by 60% and improved skin barrier function.
Showed selective antimicrobial activity against pathogenic bacteria while preserving beneficial gut microbiota.
Plain-English guides and study summaries from published literature.
Guides
7 min
KPV is an alpha-MSH fragment studied mainly for anti-inflammatory signalling, gut health and skin inflammation. This guide explains its mechanism, research status and sourcing considerations in South Africa.
Read article
Guides
9 min
KPV peptide is a small alpha-MSH fragment studied for anti-inflammatory signalling, especially NF-κB inhibition. This guide separates the pre-clinical evidence from weight loss and wellness claims.
Read article
Guides
6 min
KPV is an emerging research peptide best known for anti-inflammatory signalling hypotheses. This guide explains its cardiovascular context, how it differs from TB-500, and what to check when comparing suppliers in South Africa.
Read articleBe the first to know when prices drop on your favourite peptides
No spam. Unsubscribe anytime. We respect your privacy.